Prognosis
Omicron-Targeting Boosters From Moderna, Pfizer Ready for US Use
- Both vaccines get 13-1 votes from advisers in support
- Shots could become available as soon as this weekend
A resident receives a Covid-19 booster shot at a vaccine clinic in Lansdale, Penn., on Apr. 5.
Photographer: Hannah Beier/BloombergThis article is for subscribers only.
Covid booster shots that target the most common new variants of the virus should become available in the US within days, after the Centers for Disease Control and Prevention signed off on the rollout of updated vaccines Thursday.
CDC Director Rochelle Walensky endorsed the use of the new shots after, in two 13-1 votes, outside vaccine and health experts gave their backing to the booster shots from Moderna Inc. and from Pfizer Inc. and BioNTech SE.